Medical Nanotechnology Markets

Questions: Discounts, Updates etc.

Pages: 183

Price (Single): $3400

Price (Company): $6800

Publication Date: 2008-09-01

Order Online Now

People that purchased this report also purchased:

Contact LeadDiscovery

  • If you have questions about this report
  • To find out if you qualify for a discount
  • Want a more up to date version
  • Can't find a report that meets your needs
Search all reports

Keywords:

Boolean terms AND, OR, NOT can be used. Phrases should be entered within quotes. For wildcards use an *

Nanotechnology has reached critical mass. Nowhere is this more evident than in medicine.

Rising medical costs, demands for less-invasive procedures and pressures for immediate feedback of medical conditions, all point to nanotechnology as offering a new approach in healthcare. According to U.S. National Science Foundation estimates, by 2015 the annual global market for nano-related goods and services will top $1 trillion, thus making it one of the fastest-growing industries in history. Assuming that these figures prove to be accurate, nanotechnology will emerge as a larger economic force than the combined telecommunications and information technology industries at the beginning of the technology boom of the late 1990s.

This report covers the specific segments of the medical nanotechnology markets, with particular emphasis on those segments where this emerging technology is or shows the potential to be most impactful.

Nanotechnology, a field of science and technology that aims to control matter at the atomic, molecular and macromolecular level, potentially has far-reaching and paradigm-shifting implications for biology, drug discovery and medical technologies. The discipline has already yielded healthcare discoveries that have been used for drug delivery and diagnostic purposes.

This report describes various nanotechnologies under development for biological and medical purposes and assess their potential. Moreover, this analysis is arranged to provide an overview of the regulatory issues faced by the medical nanotechnology industry and focuses on how specific segments within the industry are poised for high future growth.

Table of Contents

  • LIST OF FIGURES

  • Figure 2.1: End-User Markets for Nanotechnology, 200715
  • Figure 2.2: Nanometer Scale18
  • Figure 2.3: International Per Capita Healthcare Spending by Country, 200622
  • Figure 2.4: World Nanomedical Market Shares, 200723
  • Figure 2.5: Total Spending on Healthcare in the U.S., 1960 to 200724
  • Figure 3.1: Nanotechnology Applications33
  • Figure 3.2: Carbon Nanotubes44
  • Figure 4.1: Depiction of nab Technology49
  • Figure 7.1: FDA Product Validation Chart133
  • Figure 7.2: FDA Product Lifecycle Model135
  • Figure 8.1: Sigma Aldrich Sales Distribution172


  • LIST OF TABLES

  • Table 2.1: Global Market for Nanotechnology Products, 2005 to 201315
  • Table 2.2: Nanotechnology Materials for Consumer Products, 2005 to 201316
  • Table 2.3: Nanotechnology Markets Worldwide by Industry, 2002 to 201516
  • Table 2.4: Nanotechnology Development Worldwide by Region, 2002 to 201516
  • Table 2.5: Currently-Growing Nanofabrication Techniques18
  • Table 2.6: Global Nanomedicine Market, 2004 to 201322
  • Table 2.7: Nanomedicine Market Revenues by Product Segment, 200723
  • Table 2.8: Global Nanomedicine Market by Geographic Segment, 2004 to 201323
  • Table 2.9: U.S. Nanomedicine Market, 2004 to 201324
  • Table 2.10: European Nanomedicine Market, 2004 to 201325
  • Table 2.11: Japanese Nanomedicine Market, 2004 to 201326
  • Table 2.12: Japanese Nanotechnology Product Market Forecast27
  • Table 2.13: Government Funding for Nanotechnology Research and Development, 1997 to 200830
  • Table 2.14: Global Nanotechnology R&D Spending, 1997 to 201330
  • Table 2.15: Global Growth in Nanotechnology R&D, 1997 to 201331
  • Table 3.1: Global Market for Nanotechnology Applications in the Life Sciences, 2005 to 201232
  • Table 3.2: Market for Nano-Particles in Life Sciences and Medicine, 2004 to 201234
  • Table 3.2: Market for Nanostructured Materials in Life Sciences and Medicine, 2004 to 201237
  • Table 3.4: Market for Nanodevices in Life Sciences and Medicine, 2004 to 201239
  • Table 3.5: Commercial Applications of Quantum Dots40
  • Table 3.6: Market for Nanocomposites in Life Sciences and Medicine, 2004 to 201242
  • Table 3.7: Liposomal Formulations Used in Nanotechnology45
  • Table 3.8: Types of Nanoparticulate Drug Delivery Systems47
  • Table 4.1: FDA-Approved Drugs Developed with Nanotechnology-Based Formulations49
  • Table 4.2: Key Effectors of Drug Delivery Using Nanomaterials50
  • Table 4.3: Nanoscale Applications for Drug Delivery in Pharmaceutical Drug Development51
  • Table 4.4: Drug Delivery Nanotechnology Market Drivers Ranked in Order of Impact51
  • Table 4.5: Drug Delivery Nanotechnology Market Restraints Ranked in Order of Impact51
  • Table 4.6: Anti-Cancer Drugs Formulated Using Nanomaterials54
  • Table 4.7: Nanomaterials for in vitro RNAi Delivery54
  • Table 4.8: Use of Peptide-Based Nanotubes for Biological Active Targets55
  • Table 4.9: Lab-on-Chip and Microfluidic Chip Technology Innovations62
  • Table 4.10: Diagnostic Nanotechnology Market Drivers Ranked in Order of Impact63
  • Table 4.11: Diagnostic Nanotechnology Market Restraints Ranked in Order of Impact63
  • Table 4.12: FDA-Approved In Vivo Imaging Materials Developed with Nanotechnology-Based Formulations64
  • Table 4.13: Application Areas for Phage Nanotechnology Platforms66
  • Table 4.14: Application Areas for Neuroscience Nanotechnology Platforms66
  • Table 4.15: Nanotechnology Application Areas for Medical Nanomaterials67
  • Table 4.16: FDA-Approved Dental Biomaterials Developed with Nanotechnology-Based Formulations68
  • Table 4.17: Drug Discovery Nanotechnology Market Drivers Ranked in Order of Impact68
  • Table 4.18: Drug Discovery Nanotechnology Market Restraints Ranked in Order of Impact68
  • Table 4.19: Examples of Proposed U.S. NNI Interagency Collaborative Activities70
  • Table 5.1: Medical Nanotechnology Market Drivers-Global, 2008 to 201675
  • Table 5.2: Medical Nanotechnology Market Restraints-Global, 2008 to 201675
  • Table 5.3: U.S. Nanotechnology Patents Issued per Year, 1996 to 200678
  • Table 5.4: Sources of Nanotechnology Funds79
  • Table 5.5: National Government Funding Leaders for Nanotechnology, 200779
  • Table 5.6: Total Investments in Venture-Backed Nanotechnology Companies, 1997 to 200881
  • Table 5.7: Leading Nanotechnology Start-Up Companies81
  • Table 6.1: Summary of Key Advantages for Nanotechnology96
  • Table 6.2: Nanotechnology Platforms Used for Diagnostics and Imaging96
  • Table 6.3: FDA-Approved In Vitro Diagnostics Developed with Nanotechnology-Based Formulations97
  • Table 6.4: Applications of Veridex Nanotechnology Platform for Diagnostic Assays98
  • Table 6.5: Characteristics of Gold Nano-Particle Technology for Diagnostic Testing100
  • Table 6.6: Overview of Future Nanomedical Technology Development101
  • Table 6.7: Recent Developments in Nanotechnology for Drug Delivery and Drug Discovery101
  • Table 6.8: Recent Developments in Nanomaterials and Nanotechnology-Based Devices102
  • Table 6.9: Recent Nanotechnology Applications in Diagnostics102
  • Table 6.10: Future Nanomedical Technology Platforms102
  • Table 6.11: Additional Global Market Trends127
  • Table 8.1: AMAG Nanotechnology Products and Candidates149

    • Other users found this report page using the following search terms: Nanotechnology nanotechnology medical companies market drug medicine markets nano use nanotech

    If you can't find a report that meets your needs contact LeadDiscovery. We are one of the few report providers with extensive drug development experience and we frequently use this knowledge to help clients source the most appropriate reports or produce reports for them from scratch.


    Refund and Cancellation Policy: The descriptions of the products and services sold on LeadDiscovery.co.uk are as complete and accurate as possible, and customers are encouraged to read all available information about a product before placing an order. Due to the nature of the information being sold, orders for reports cannot be canceled.